On Wednesday, both Pfizer Inc. (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) shares edged lower to extend this week’s declines despite reporting positive developments. On Monday, the Pfizer/BioNTech covid-19 vaccine received full approval from the US Food and Drug Administration for use on people aged 16 years and over. The announcement triggered a more than 4% […]
Full ArticleWhat’s the better stock to buy: Pfizer or J&J?
Invezz
0 shares
1 views
You might like
Related news coverage
-
Better Dividend Stock: Johnson & Johnson or Pfizer?
Motley Fool
-
Better Dividend Stock: AbbVie or Pfizer?
Motley Fool